AI-powered formulation design: Neural networks in drug development

Neural networks are a key component of formulation design, and the integration of artificial intelligence (AI) into drug development is revolutionizing the pharmaceutical industry. To solve the issues of cost, accuracy, and efficiency, AI-powered models—in particular, deep learning networks—are being used more and more to forecast and optimize medication compositions. Neural networks are capable of predicting solubility, stability, and bioavailability as well as suggesting optimal compositions by examining large datasets and identifying non-linear correlations between formulation components. The time required to produce new medications is greatly decreased by this methodology, which speeds up the conventional trial-and-error method. AI may also improve personalized medicine by customizing medication formulas to meet the demands of each patient. The use of neural networks in drug formulation is examined in this research, which also highlights recent developments, difficulties, and potential paths for AI-powered drug development.